These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

605 related items for PubMed ID: 12416660

  • 1. Glycaemic control and microvascular complications in a large cohort of Italian Type 1 diabetic out-patients.
    Lepore G, Bruttomesso D, Nosari I, Tiengo A, Trevisan R.
    Diabetes Nutr Metab; 2002 Aug; 15(4):232-9. PubMed ID: 12416660
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Burden and pattern of micro vascular complications in type 2 diabetes in a tertiary health institution in Nigeria.
    Olamoyegun M, Ibraheem W, Iwuala S, Audu M, Kolawole B.
    Afr Health Sci; 2015 Dec; 15(4):1136-41. PubMed ID: 26958014
    [Abstract] [Full Text] [Related]

  • 6. The association of chronic complications with time in tight range and time in range in people with type 1 diabetes: a retrospective cross-sectional real-world study.
    De Meulemeester J, Charleer S, Visser MM, De Block C, Mathieu C, Gillard P.
    Diabetologia; 2024 Aug; 67(8):1527-1535. PubMed ID: 38787436
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Risk factors for microvascular complications of diabetes among South Indian subjects with type 2 diabetes--the Chennai Urban Rural Epidemiology Study (CURES) Eye Study-5.
    Pradeepa R, Anjana RM, Unnikrishnan R, Ganesan A, Mohan V, Rema M.
    Diabetes Technol Ther; 2010 Oct; 12(10):755-61. PubMed ID: 20818974
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Association of differing dietary, metabolic, and clinical risk factors with microvascular complications of diabetes: a prevalence study of 503 Mexican type II diabetic subjects. II.
    Paisey RB, Arredondo G, Villalobos A, Lozano O, Guevara L, Kelly S.
    Diabetes Care; 1984 Oct; 7(5):428-33. PubMed ID: 6499636
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Visit-to-visit systolic blood pressure variability and microvascular complications among patients with diabetes.
    Sohn MW, Epstein N, Huang ES, Huo Z, Emanuele N, Stukenborg G, Guihan M, Li J, Budiman-Mak E.
    J Diabetes Complications; 2017 Jan; 31(1):195-201. PubMed ID: 27671535
    [Abstract] [Full Text] [Related]

  • 15. The relation between QTc interval prolongation and diabetic complications. The EURODIAB IDDM Complication Study Group.
    Veglio M, Borra M, Stevens LK, Fuller JH, Perin PC.
    Diabetologia; 1999 Jan; 42(1):68-75. PubMed ID: 10027581
    [Abstract] [Full Text] [Related]

  • 16. Risk factors for the development of micro-vascular complications of type 2 diabetes in a single-centre cohort of patients.
    Teliti M, Cogni G, Sacchi L, Dagliati A, Marini S, Tibollo V, De Cata P, Bellazzi R, Chiovato L.
    Diab Vasc Dis Res; 2018 Sep; 15(5):424-432. PubMed ID: 29911415
    [Abstract] [Full Text] [Related]

  • 17. Can glycaemic variability, as calculated from blood glucose self-monitoring, predict the development of complications in type 1 diabetes over a decade?
    Bragd J, Adamson U, Bäcklund LB, Lins PE, Moberg E, Oskarsson P.
    Diabetes Metab; 2008 Dec; 34(6 Pt 1):612-6. PubMed ID: 18824382
    [Abstract] [Full Text] [Related]

  • 18. Good glycemic control remains crucial in prevention of late diabetic complications--the Linköping Diabetes Complications Study.
    Nordwall M, Arnqvist HJ, Bojestig M, Ludvigsson J.
    Pediatr Diabetes; 2009 May; 10(3):168-76. PubMed ID: 19175900
    [Abstract] [Full Text] [Related]

  • 19. Development of Microvascular Complications and Effect of Concurrent Risk Factors in Type 1 Diabetes: A Multistate Model From an Observational Clinical Cohort Study.
    Bjerg L, Hulman A, Carstensen B, Charles M, Jørgensen ME, Witte DR.
    Diabetes Care; 2018 Nov; 41(11):2297-2305. PubMed ID: 30131399
    [Abstract] [Full Text] [Related]

  • 20. Lipid and blood pressure treatment goals for type 1 diabetes: 10-year incidence data from the Pittsburgh Epidemiology of Diabetes Complications Study.
    Orchard TJ, Forrest KY, Kuller LH, Becker DJ, Pittsburgh Epidemiology of Diabetes Complications Study.
    Diabetes Care; 2001 Jun; 24(6):1053-9. PubMed ID: 11375370
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.